A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Oral Lixivaptan Capsules in Subjects With Euvolemic Hyponatremia
PHASE3
The purpose of this study is to evaluate the safety and tolerability of ora...
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Oral Lixivaptan Capsules in Subject With Euvolemic Hyponatremia
PHASE3
The present study is designed to confirm and extend the observation from pr...
International, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatremia: Extension to Studies CK-LX3401, 3405, and 3430
N/A
To evaluate the overall safety and continued efficacy of oral lixivaptan ca...
Status
Completed
Location
Torrance Clinical Research
Start Date
2010-01
Trial ID
NCT01056848
The ELiSA Study - Evaluation of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease
PHASE2
This is a Phase 2, open-label, parallel-group, multiple dose study designed...